Navigation Links
Quantum Materials Corporation Announces Non-Heavy Metal (Cadmium-Free) Tetrapod Quantum Dots
Date:2/12/2013

CARSON CITY, Nev., Feb. 12, 2013 /PRNewswire/ -- Quantum Materials Corporation (QMC) (OTCQB:QTMM) announces a new class of cadmium-free, non-REE, non-heavy metal tetrapod quantum dots (NHM-TPQD) developed to meet worldwide concerns regarding nanoparticle biocompatibility and sustainability.

(Logo:  http://photos.prnewswire.com/prnh/20121120/DA16554LOGO)

QMC can produce industrial scale quantities of NHM-TPQD using proprietary continuous flow chemistry processes with over 90% tetrapod shape and size uniformity, unmatched in the industry. The new availability of a reliable supply of high quantities of uniform and low cost non-heavy metal tetrapod quantum dots will spur development of products and applications in next-generation displays, sensors, biomedical research, diagnostics and drug delivery, security and conductive inks, solid-state lighting (SSL) and photovoltaic solar cells, currently under development by QMC subsidiary Solterra Renewable Technologies.

Quantum dots in biomedical imaging are unique fluorescent probes with advantages over dyes and other fluorophores. QMC has made improvements in quantum dot brightness (high quantum yield), photostability for longer sample lifetime, high uniformity, narrow band, wide spectrum, and tunable emission spectrum. According to a 2012 market research report by Global Industry Analyst, Inc., the total market for Global BioImaging Technologies in 2017 is forecast to reach $34.7 billion.

In 2011, Quantum Materials and NanoAxis LLC pioneered a Joint Alliance to develop Tetrapod Quantum Dot based Cancer diagnostic kits and theranostic applications including Alzheimer's, Type 1 and Type 2 Diabetes, Breast Cancer and Major Depression.

Quantum Materials CEO and Founder, Mr. Stephen Squires commented, "While our cadmium-based high-brightness tetrapod quantum dots are unparalleled in photovoltaic solar cell applications and especially for commercializing high value, small quantity in vitro research and lab applications, our non-heavy metal tetrapod quantum dot answers the world's ecological and in vivo human toxicological concerns for mass-produced QD in the biotech and other fields of science."

Quantum Materials Corporation is poised to become the world's largest manufacturer of quantum dots by scaling production to multiple kilograms per day in 2013. QMC's production is not subject to any other manufacturer's patents and QMC is free to joint venture and to license its technology.

Mr. Squires is speaking at the CHI Emerging Diagnostics Partnering Forum in San Francisco this week on quantum dot applications in the next generation of diagnostic assays, multiplexed drug delivery platforms and handheld POC devices. Quantum Materials Corporation is then exhibiting at the CHI Molecular Med Tri-Conference on February 13-14, Booth 622.

About Quantum Materials Corporation and its subsidiary, Solterra Renewable Technologies

QUANTUM MATERIALS CORPORATION, INC. has a steadfast vision that advanced technology is the solution to the most challenging of global issues. Quantum Materials Corporation is devoted to the deployment of technologies to invigorate the development of disruptive solutions through cost reduction and moving laboratory discovery to commercialization with volume manufacturing methods to establish a growing line of innovative high performance products.

(http://www.quantummaterials.us)

SOLTERRA RENEWABLE TECHNOLOGIES, INC., a wholly-owned subsidiary of Quantum Materials Corporation, is developing thin-film quantum dot solar cell technology.

(http://www.solterrasolarcells.com)

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at http://www.sec.gov/ or from our website. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.

Contact: Art Lamstein
Quantum Materials Corp.
Director of Marketing  
artlamstein@qmcdots.com


'/>"/>
SOURCE Quantum Materials Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Invisible tool enables new quantum experiments
2. Using single quantum dots to probe nanowires
3. Revolutionary Tetrapod Quantum Dot Synthesis US Patent Granted
4. Lava dots: Rice makes hollow, soft-shelled quantum dots
5. Scientists demonstrate high-efficiency quantum dot solar cells
6. Single-atom writer a landmark for quantum computing
7. The quantum world only partially melts
8. Imprisoned molecules quantum rattle in their cages
9. Nature: Electronic read-out of quantum bits
10. Quantum physics: New insights into the remote control of quantum systems
11. UK research paves way to a scalable device for quantum information processing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... (PRWEB) , ... December 09, 2016 , ... DuPont ... honored with the Breakthrough Solution of the Year Award from Platts Global Energy ... ester (FDME). The award was announced at the 18th Platts Global Energy Awards, ...
(Date:12/9/2016)... TORONTO , Dec. 9, 2016 /PRNewswire/ - Portage ... Securities Exchange: PBT.U), is pleased to announce that Biohaven ... New Haven, Connecticut (PRWEB) Dec ... "Company" or "Biohaven") announced today that the U.S. Food ... drug designation request covering its drug candidate BHV-0223, an ...
(Date:12/8/2016)... Dec. 8, 2016  OncoSec Medical Incorporated ("OncoSec") ... DNA-based intratumoral cancer immunotherapies, today announced financial results ... "We are delivering on our commitment to ... ImmunoPulse┬« IL-12. We are pleased with the early ... trial, and we are focused on advancing our ...
(Date:12/8/2016)... , Dec. 8, 2016 Eurofins announces the appointment of ... President of Eurofins Scientific Inc. (ESI). Mr. Murray ... proven professional and entrepreneurial experience in leading international business teams. As ... food testing market to uphold Eurofins, status as the global leader ... , ...
Breaking Biology Technology:
(Date:11/17/2016)... Market Watch: Primarily supported by ownership types; Private ... market is to witness a value of US$37.1 billion by ... Annual Growth Rate (CAGR) of 10.75% is foreseen from ... North America is not way behind ... at 9.56% respectively. Report Focus: The ...
(Date:11/15/2016)... , Nov 15, 2016 Research and ... Global Forecast to 2021" report to their offering. ... ... USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, ... Growth of the bioinformatics market is driven by the ...
(Date:6/22/2016)... , June 22, 2016  The American College of ... Trade Show Executive Magazine as one of the fastest-growing ... May 25-27 at the Bellagio in Las Vegas ... the highest percentage of growth in each of the following ... exhibiting companies and number of attendees. The 2015 ACMG Annual ...
Breaking Biology News(10 mins):